Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christopher B. Fordyce, MDCM, MHS, MSc"'
Autor:
Curtis Williams, MD, Christopher B. Fordyce, MDCM, MHS, MSc, John A. Cairns, MD, Ricky D. Turgeon, BSc(Pharm), ACPR, PharmD, Terry Lee, PhD, Joel Singer, PhD, Martha Mackay, PhD, RN, Graham C. Wong, MD, MPH
Publikováno v:
CJC Open, Vol 5, Iss 3, Pp 181-190 (2023)
Background: The Vancouver Coastal Health (VCH) ST-elevation myocardial infarction (STEMI) program aimed to increase access to primary percutaneous coronary intervention (PPCI) and reduce first-medical-contact-to-device times (FMC-DTs). We evaluated t
Externí odkaz:
https://doaj.org/article/83190a7feae4467baea0f7371e36a271
Autor:
Michael J. Thibert, MD, Christopher B. Fordyce, MDCM, MHS, MSc, John A. Cairns, MD, MSc, Ricky D. Turgeon, BSc(Pharm), ACPR, PharmD, Martha Mackay, PhD, RN, Terry Lee, PhD, Wendy Tocher, RN, Joel Singer, PhD, Michele Perry-Arnesen, MHA, RN, Graham C. Wong, MD, MPH
Publikováno v:
CJC Open, Vol 3, Iss 7, Pp 864-871 (2021)
Background: Major bleeding (MB) is an independent predictor of mortality among ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). Prevention of access-site MB has received significant att
Externí odkaz:
https://doaj.org/article/e9a2b3dea5b94df38136f093342cf4e4